Clinical Trials Directory

Trials / Completed

CompletedNCT03812575

The Use of Fractionated Exhaled Nitric Oxide in the Diagnosis and Assessment of Disease Activity of Eosinophilic Esophagitis (Pilot)

The Use of Fractionated Exhaled Nitric Oxide in the Diagnosis and Assessment of Disease Activity of Eosinophilic Esophagitis

Status
Completed
Phase
Study type
Observational
Enrollment
80 (actual)
Sponsor
The University of Texas Health Science Center, Houston · Academic / Other
Sex
All
Age
5 Years – 18 Years
Healthy volunteers
Not accepted

Summary

The purpose of the study is to evaluate of the relationships between fractionated exhaled nitric oxide, disease activity, and symptom severity in patients with eosinophilic esophagitis compared to those without eosinophilic esophagitis.

Conditions

Timeline

Start date
2019-01-31
Primary completion
2020-06-01
Completion
2020-06-01
First posted
2019-01-23
Last updated
2024-05-10

Locations

1 site across 1 country: United States

Source: ClinicalTrials.gov record NCT03812575. Inclusion in this directory is not an endorsement.